Aptean's Food and Beverage Partner Network Drives Record ERP Growth; Sparking Global Expansion of Partner Program
Notified -
Globe Newswire29-07-2025, 22:56
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer 8-10-2025, 18:09
